Richard A Young - Net Worth and Insider Trading
Richard A Young Net Worth
The estimated net worth of Richard A Young is at least $2 Million dollars as of 2024-04-26. Richard A Young is the Director of Omega Therapeutics Inc and owns about 744,118 shares of Omega Therapeutics Inc (OMGA) stock worth over $2 Million. Richard A Young is the Director of Syros Pharmaceuticals Inc and owns about 32,171 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $160,855. Richard A Young is also the Director of Enzon Pharmaceuticals Inc and owns about 19,562 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $1,458. Details can be seen in Richard A Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard A Young has not made any transactions after 2023-05-01 and currently still holds the listed stock(s).
Transaction Summary of Richard A Young
Richard A Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard A Young owns 3 companies in total, including Syros Pharmaceuticals Inc (SYRS) , Enzon Pharmaceuticals Inc (ENZN) , and Omega Therapeutics Inc (OMGA) .
Click here to see the complete history of Richard A Young’s form 4 insider trades.
Insider Ownership Summary of Richard A Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2021-02-16 | director |
| ENZN | Enzon Pharmaceuticals Inc | 2012-03-15 | director |
| OMGA | Omega Therapeutics Inc | 2023-05-01 | director & 10 percent owner |
Richard A Young Latest Holdings Summary
Richard A Young currently owns a total of 3 stocks. Among these stocks, Richard A Young owns 744,118 shares of Omega Therapeutics Inc (OMGA) as of May 1, 2023, with a value of $2 Million and a weighting of 91.23%. Richard A Young owns 32,171 shares of Syros Pharmaceuticals Inc (SYRS) as of February 16, 2021, with a value of $160,855 and a weighting of 8.69%. Richard A Young also owns 19,562 shares of Enzon Pharmaceuticals Inc (ENZN) as of March 15, 2012, with a value of $1,458 and a weighting of 0.08%.
Latest Holdings of Richard A Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OMGA | Omega Therapeutics Inc | 2023-05-01 | 744,118 | 2.27 | 1,689,148 |
| SYRS | Syros Pharmaceuticals Inc | 2021-02-16 | 32,171 | 5.00 | 160,855 |
| ENZN | Enzon Pharmaceuticals Inc | 2012-03-15 | 19,562 | 0.07 | 1,458 |
Holding Weightings of Richard A Young
Richard A Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard A Young has made a total of 5 transactions in Omega Therapeutics Inc (OMGA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Omega Therapeutics Inc is the sale of 5,000 shares on May 1, 2023, which brought Richard A Young around $40,000.
According to the SEC Form 4 filings, Richard A Young has made a total of 13 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 375 shares on February 16, 2021, which brought Richard A Young around $45,188.
According to the SEC Form 4 filings, Richard A Young has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the sale of 2,000 shares on March 15, 2012, which brought Richard A Young around $13,840.
Insider Trading History of Richard A Young
- 1
Richard A Young Trading Performance
Richard A Young Ownership Network
Ownership Network List of Richard A Young
Ownership Network Relation of Richard A Young
Richard A Young Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Richard A Young is the director of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Medical Officer David Roth , Chief Scientific Officer Eric R Olson , and Chief Financial Officer Jason Haas .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Richard A Young made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .
In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Richard A Young Mailing Address
Above is the net worth, insider trading, and ownership report for Richard A Young. You might contact Richard A Young via mailing address: C/o Syros Pharmaceuticals, Inc., 620 Memorial Drive Suite 300, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
